{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:21:20Z","timestamp":1784132480066,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05279-5","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T16:51:23Z","timestamp":1676047883000},"page":"1101-1109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Myositis autoantibodies detected by line blot immunoassay: clinical associations and correlation with antibody signal intensity"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1352-9539","authenticated-orcid":false,"given":"Jes\u00fas","family":"Loarce-Martos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Calvo Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1154-8832","authenticated-orcid":false,"given":"Sandra","family":"Garrote-Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4915-0483","authenticated-orcid":false,"given":"Rub\u00e9n","family":"Ballester Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9323-5236","authenticated-orcid":false,"given":"Roberto","family":"Pariente Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2103-0973","authenticated-orcid":false,"given":"Claudia Geraldine","family":"Rita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Garc\u00eda-Soidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8954-209X","authenticated-orcid":false,"given":"Javier","family":"Bachiller-Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garbi\u00f1e","family":"Roy Ari\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"key":"5279_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","volume":"101","author":"Z Betteridge","year":"2019","unstructured":"Betteridge Z, Tansley S, Shaddick G et al (2019) Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J Autoimmun 101:48\u201355. https:\/\/doi.org\/10.1016\/j.jaut.2019.04.001","journal-title":"J Autoimmun"},{"key":"5279_CR2","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.55563\/clinexprheumatol\/tt4ilu","volume":"39","author":"R Baumberger","year":"2021","unstructured":"Baumberger R, Jordan S, Distler O et al (2021) Diagnostic measures for patients with systemic sclerosis-associated myopathy. Clin Exp Rheumatol 39:S85\u2013S93. https:\/\/doi.org\/10.55563\/clinexprheumatol\/tt4ilu","journal-title":"Clin Exp Rheumatol"},{"key":"5279_CR3","first-page":"S3","volume":"39","author":"MB Adarsh","year":"2021","unstructured":"Adarsh MB, Kavadichanda CG, Shah S, Negi VS (2021) Anti Ku antibody is associated with haematological manifestations but not with overlap features in systemic lupus erythematosus. Clin Exp Rheumatol 39:S3\u2013S4","journal-title":"Clin Exp Rheumatol"},{"key":"5279_CR4","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00296-017-3718-1","volume":"37","author":"AYS Lee","year":"2017","unstructured":"Lee AYS (2017) A review of the role and clinical utility of anti-Ro52\/TRIM21 in systemic autoimmunity. Rheumatol Int 37:1323\u20131333","journal-title":"Rheumatol Int"},{"key":"5279_CR5","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/141181","author":"A Rams","year":"2021","unstructured":"Rams A, Kosa\u0142ka-W\u0229giel J, Kuszmiersz P et al (2021) Characteristics of idiopathic inflammatory myopathies with novel myositis-specific autoantibodies. Adv Clin Exp Med. https:\/\/doi.org\/10.17219\/acem\/141181","journal-title":"Adv Clin Exp Med"},{"key":"5279_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8112013","author":"L Cavagna","year":"2019","unstructured":"Cavagna L, Trallero-Aragu\u00e1s E, Meloni F et al (2019) Clinical medicine influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course. J Clin Med. https:\/\/doi.org\/10.3390\/jcm8112013","journal-title":"J Clin Med"},{"key":"5279_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","volume":"14","author":"IE Lundberg","year":"2018","unstructured":"Lundberg IE, de Visser M, Werth VP (2018) Classification of myositis. Nat Rev Rheumatol 14:269\u2013278. https:\/\/doi.org\/10.1038\/nrrheum.2018.41","journal-title":"Nat Rev Rheumatol"},{"key":"5279_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41927-020-00132-9","volume":"4","author":"F To","year":"2020","unstructured":"To F, Vent\u00edn-rodr\u00edguez C, Elkhalifa S et al (2020) Line blot immunoassays in idiopathic inflammatory myopathies: Retrospective review of diagnostic accuracy and factors predicting true positive results. BMC Rheumatol 4:1\u20138. https:\/\/doi.org\/10.1186\/s41927-020-00132-9","journal-title":"BMC Rheumatol"},{"key":"5279_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2016.02.017","volume":"433","author":"I Cavazzana","year":"2016","unstructured":"Cavazzana I, Fredi M, Ceribelli A et al (2016) Testing for myositis specific autoantibodies: comparison between line blot and immunoprecipitation assays in 57 myositis sera. J Immunol Methods 433:1\u20135. https:\/\/doi.org\/10.1016\/j.jim.2016.02.017","journal-title":"J Immunol Methods"},{"key":"5279_CR10","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/rheumatology\/keaa021","volume":"59","author":"SL Tansley","year":"2020","unstructured":"Tansley SL, Li D, Betteridge ZE, McHugh NJ (2020) The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity. Rheumatol (United Kingdom) 59:2109\u20132114. https:\/\/doi.org\/10.1093\/rheumatology\/keaa021","journal-title":"Rheumatol (United Kingdom)"},{"key":"5279_CR11","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3389\/fimmu.2019.00848","volume":"10","author":"M Mahler","year":"2019","unstructured":"Mahler M, Betteridge Z, Bentow C et al (2019) Comparison of three immunoassays for the detection of myositis specific antibodies. Front Immunol 10:848. https:\/\/doi.org\/10.3389\/fimmu.2019.00848","journal-title":"Front Immunol"},{"key":"5279_CR12","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1136\/annrheumdis-2019-215884","volume":"79","author":"I Cavazzana","year":"2020","unstructured":"Cavazzana I, Fredi M, Franceschini F (2020) Semiquantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance? Ann Rheum Dis 79:e152\u2013e152. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215884","journal-title":"Ann Rheum Dis"},{"key":"5279_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.55563\/clinexprheumatol\/3cuc1s","volume":"38","author":"Y Piette","year":"2020","unstructured":"Piette Y, De Sloovere M, Vandendriessche S et al (2020) Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy. Clin Exp Rheumatol 38:212\u2013219. https:\/\/doi.org\/10.55563\/clinexprheumatol\/3cuc1s","journal-title":"Clin Exp Rheumatol"},{"key":"5279_CR14","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","volume":"41","author":"I Marie","year":"2012","unstructured":"Marie I, Hatron PY, Dominique S et al (2012) Short-term and long-term outcome of Anti-Jo1-positive patients with Anti-Ro52 antibody. Semin Arthritis Rheum 41:890\u2013899. https:\/\/doi.org\/10.1016\/j.semarthrit.2011.09.008","journal-title":"Semin Arthritis Rheum"},{"key":"5279_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02933","author":"AA Starshinova","year":"2020","unstructured":"Starshinova AA, Malkova AM, Basantsova NY et al (2020) Sarcoidosis as an autoimmune disease. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.02933","journal-title":"Front Immunol"},{"key":"5279_CR16","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/nejmra2101555","volume":"385","author":"M Drent","year":"2021","unstructured":"Drent M, Crouser ED, Grunewald J (2021) Challenges of sarcoidosis and its management. N Engl J Med 385:1018\u20131032. https:\/\/doi.org\/10.1056\/nejmra2101555","journal-title":"N Engl J Med"},{"key":"5279_CR17","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1136\/annrheumdis-2020-eular.5990","volume":"79","author":"J Loarce-Martos","year":"2020","unstructured":"Loarce-Martos J, Rita C, Ballester Gonzalez R et al (2020) FRI0250 \u201care myositis antibodies specific for idiopathic inflammatory myopathy diagnosis?\u201d Clinical correlation of a cohort of patients positive for myositis antibodies. Ann Rheum Dis 79:702\u2013709. https:\/\/doi.org\/10.1136\/annrheumdis-2020-eular.5990","journal-title":"Ann Rheum Dis"},{"key":"5279_CR18","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M et al (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76:1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"key":"5279_CR19","doi-asserted-by":"crossref","unstructured":"Allenbach Y, Mammen AL, Benveniste O, et al (2018) 224th ENMC International Workshop: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016. In: Neuromuscular Disorders. Elsevier Ltd, pp 87\u201399","DOI":"10.1016\/j.nmd.2017.09.016"},{"key":"5279_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","volume":"84","author":"Y Troyanov","year":"2005","unstructured":"Troyanov Y, Targoff IN, Tremblay JL et al (2005) Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 84:231\u2013249","journal-title":"Medicine (Baltimore)"},{"key":"5279_CR21","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1378\/chest.10-0180","volume":"138","author":"GR Connors","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV, Danoff SK (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 138:1464\u20131474","journal-title":"Chest"},{"key":"5279_CR22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/.BOR0000000000000837","volume":"33","author":"V Leclair","year":"2021","unstructured":"Leclair V, Notarnicola A, Vencovsky J, Lundberg IE (2021) Polymyositis: does it really exist as a distinct clinical subset? Curr Opin Rheumatol 33:537\u2013543. https:\/\/doi.org\/10.1097\/.BOR0000000000000837","journal-title":"Curr Opin Rheumatol"},{"key":"5279_CR23","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","volume":"17","author":"A Selva-O\u2019Callaghan","year":"2018","unstructured":"Selva-O\u2019Callaghan A, Pinal-Fernandez I, Trallero-Aragu\u00e1s E et al (2018) Classification and management of adult inflammatory myopathies. Lancet Neurol 17:816\u2013828. https:\/\/doi.org\/10.1016\/S1474-4422(18)30254-0","journal-title":"Lancet Neurol"},{"key":"5279_CR24","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/ART.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f5n GS et al (2012) Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677\u20132686. https:\/\/doi.org\/10.1002\/ART.34473","journal-title":"Arthritis Rheum"},{"key":"5279_CR25","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D et al (2019) 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78:1151\u20131159. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214819","journal-title":"Ann Rheum Dis"},{"key":"5279_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R et al (2017) 2016 American College of Rheumatology\/European League against rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 76:9\u201316. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210571","journal-title":"Ann Rheum Dis"},{"key":"5279_CR27","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Van Den Hoogen","year":"2013","unstructured":"Van Den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis 72:1747\u20131755. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424","journal-title":"Ann Rheum Dis"},{"key":"5279_CR28","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","volume":"71","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Maradit-Kremers H et al (2012) 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Ann Rheum Dis 71:484\u2013492. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200329","journal-title":"Ann Rheum Dis"},{"key":"5279_CR29","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/13993003.00150-2015","volume":"46","author":"A Fischer","year":"2015","unstructured":"Fischer A, Antoniou KM, Brown KK et al (2015) An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 46:976\u2013987. https:\/\/doi.org\/10.1183\/13993003.00150-2015","journal-title":"Eur Respir J"},{"key":"5279_CR30","doi-asserted-by":"publisher","first-page":"E26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser ED, Maier LA, Baughman RP et al (2020) Diagnosis and detection of sarcoidosis an official American thoracic society clinical practice guideline. Am J Respir Crit Care Med 201:E26\u2013E51. https:\/\/doi.org\/10.1164\/rccm.202002-0251ST","journal-title":"Am J Respir Crit Care Med"},{"key":"5279_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.12451","volume":"280","author":"Z Betteridge","year":"2016","unstructured":"Betteridge Z, McHugh N (2016) Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med 280:8\u201323. https:\/\/doi.org\/10.1111\/joim.12451","journal-title":"J Intern Med"},{"key":"5279_CR32","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/WCO.0000000000000376","volume":"29","author":"O Benveniste","year":"2016","unstructured":"Benveniste O, Stenzel W, Allenbach Y (2016) Advances in serological diagnostics of inflammatory myopathies. Curr Opin Neurol 29:662\u2013673. https:\/\/doi.org\/10.1097\/WCO.0000000000000376","journal-title":"Curr Opin Neurol"},{"key":"5279_CR33","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X20975907","author":"A Lackner","year":"2020","unstructured":"Lackner A, Tiefenthaler V, Mirzayeva J et al (2020) The use and diagnostic value of testing myositis-specific and myositis-associated autoantibodies by line immuno-assay: a retrospective study. Ther Adv Musculoskelet Dis. https:\/\/doi.org\/10.1177\/1759720X20975907","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"5279_CR34","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007188","author":"M Casal-Dominguez","year":"2019","unstructured":"Casal-Dominguez M, Pinal-Fernandez I, Corse AM et al (2019) Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000007188","journal-title":"Neurology"},{"key":"5279_CR35","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1136\/annrheumdis-2018-215004","volume":"78","author":"S Sabbagh","year":"2019","unstructured":"Sabbagh S, Pinal-Fernandez I, Kishi T et al (2019) Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis. Ann Rheum Dis 78:988\u2013995. https:\/\/doi.org\/10.1136\/annrheumdis-2018-215004","journal-title":"Ann Rheum Dis"},{"key":"5279_CR36","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3899\/jrheum.150844","volume":"43","author":"J Bauhammer","year":"2016","unstructured":"Bauhammer J, Blank N, Max R et al (2016) Rituximab in the treatment of jo1 antibody-associated antisynthetase syndrome: Anti-Ro52 positivity as a marker for severity and treatment response. J Rheumatol 43:1566\u20131574. https:\/\/doi.org\/10.3899\/jrheum.150844","journal-title":"J Rheumatol"},{"key":"5279_CR37","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1136\/annrheumdis-2018-214690","volume":"78","author":"F Espinosa-Ortega","year":"2019","unstructured":"Espinosa-Ortega F, Holmqvist M, Alexanderson H et al (2019) Comparison of autoantibody specificities tested by a line blot assay and immunoprecipitation-based algorithm in patients with idiopathic inflammatory myopathies. Ann Rheum Dis 78:858\u2013860. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214690","journal-title":"Ann Rheum Dis"},{"key":"5279_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14174","author":"TJ Beaton","year":"2021","unstructured":"Beaton TJ, Gillis D, Prain K et al (2021) Performance of myositis-specific antibodies detected on myositis line immunoassay to diagnose and sub-classify patients with suspected idiopathic inflammatory myopathy, a retrospective records-based review. Int J Rheum Dis. https:\/\/doi.org\/10.1111\/1756-185X.14174","journal-title":"Int J Rheum Dis"},{"key":"5279_CR39","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/art.41088","volume":"72","author":"CA Mecoli","year":"2020","unstructured":"Mecoli CA, Casal-Dominguez M, Pak K et al (2020) Myositis autoantibodies: a comparison of results from the oklahoma medical research foundation myositis panel to the Euroimmun research line blot. Arthritis Rheumatol 72:192. https:\/\/doi.org\/10.1002\/art.41088","journal-title":"Arthritis Rheumatol"},{"key":"5279_CR40","first-page":"S12","volume":"30","author":"WK Robert","year":"2012","unstructured":"Robert WK, Noreen F, Mary RL et al (2012) Anti-PM-Scl antibody in patients with systemic sclerosis. Clin Exp Rheumatol 30:S12\u2013S16","journal-title":"Clin Exp Rheumatol"},{"key":"5279_CR41","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/rheumatology\/key343","volume":"58","author":"MJS Parker","year":"2019","unstructured":"Parker MJS, Oldroyd A, Roberts ME et al (2019) The performance of the European League Against Rheumatism\/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort. Rheumatology 58:468\u2013475. https:\/\/doi.org\/10.1093\/rheumatology\/key343","journal-title":"Rheumatology"},{"key":"5279_CR42","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/rheumatology\/keab492","volume":"61","author":"V Leclair","year":"2022","unstructured":"Leclair V, D\u2019Aoust J, Gyger G et al (2022) Autoantibody profiles delineate distinct subsets of scleromyositis. Rheumatology 61:1148\u20131157. https:\/\/doi.org\/10.1093\/rheumatology\/keab492","journal-title":"Rheumatology"},{"key":"5279_CR43","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1136\/annrheumdis-2019-215099","volume":"78","author":"K Yamamoto","year":"2019","unstructured":"Yamamoto K, Okada Y (2019) Shared genetic factors and their causality in autoimmune diseases. Ann Rheum Dis 78:1449\u20131451. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215099","journal-title":"Ann Rheum Dis"},{"key":"5279_CR44","doi-asserted-by":"publisher","first-page":"108355","DOI":"10.18632\/oncotarget.19383","volume":"8","author":"M Luan","year":"2017","unstructured":"Luan M, Shang Z, Teng Y et al (2017) The shared and specific mechanism of four autoimmune diseases. Oncotarget 8:108355. https:\/\/doi.org\/10.18632\/oncotarget.19383","journal-title":"Oncotarget"},{"key":"5279_CR45","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jbspin.2015.12.005","volume":"84","author":"S Rodr\u00edguez-Muguruza","year":"2017","unstructured":"Rodr\u00edguez-Muguruza S, Lozano-Ramos I, Coll-Canti J et al (2017) Anti-SRP auto-antibodies are not specific for myositis: report of 8 cases. Jt Bone Spine 84:103\u2013105. https:\/\/doi.org\/10.1016\/j.jbspin.2015.12.005","journal-title":"Jt Bone Spine"},{"key":"5279_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/S13317-013-0046-7","volume":"4","author":"T Himoto","year":"2013","unstructured":"Himoto T, Nishioka M (2013) Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis. Auto-Immun Highlights 4:39. https:\/\/doi.org\/10.1007\/S13317-013-0046-7","journal-title":"Auto-Immun Highlights"},{"key":"5279_CR47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","volume":"21","author":"NK Gatselis","year":"2015","unstructured":"Gatselis NK, Zachou K, Koukoulis GK, Dalekos GN (2015) Autoimmune hepatitis, one disease with many faces: Etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol 21:60. https:\/\/doi.org\/10.3748\/wjg.v21.i1.60","journal-title":"World J Gastroenterol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05279-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05279-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05279-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T16:03:47Z","timestamp":1682352227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05279-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["5279"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05279-5","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,10]]},"assertion":[{"value":"12 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no affiliations with or involvement in any organization or entity with any financial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study (<i>study number 054.21, protocol v1.1<\/i>) was approved by the local ethics committee of our hospital (Comit\u00e9 de \u00e9tica de la investigaci\u00f3n con medicamentos del Hospital Universitario Ram\u00f3n y Cajal) on 12\/03\/2021. Patient\u2019s consent was deemed unnecessary owing to the non-interventional design of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}